Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in mice

  1. Mattia Volta
  2. Dayne A Beccano-Kelly
  3. Sarah A Paschall
  4. Stefano Cataldi
  5. Sarah E MacIsaac
  6. Naila Kuhlmann
  7. Chelsie A Kadgien
  8. Igor Tatarnikov
  9. Jesse Fox
  10. Jaskaran Khinda
  11. Emma Mitchell
  12. Sabrina Bergeron
  13. Heather Melrose
  14. Matthew J Farrer
  15. Austen J Milnerwood  Is a corresponding author
  1. Institute for Biomedicine, Italy
  2. University of Oxford, United Kingdom
  3. University of British Columbia, Canada
  4. Mayo Clinic, United States
  5. Montreal Neurological Institute, McGill University, Canada

Abstract

LRRK2 mutations produce end-stage Parkinson’s disease (PD) with reduced nigrostriatal dopamine. Conversely, asymptomatic carriers have increased dopamine turnover and altered brain connectivity. LRRK2 pathophysiology remains unclear, but reduced dopamine and mitochondrial abnormalities occur in aged mutant knock-in (GKI) mice. Conversely, cultured GKI neurons exhibit increased synaptic transmission. We assessed behavior and synaptic glutamate and dopamine function across ages. Young GKI exhibit more vertical exploration, elevated glutamate and dopamine transmission, and aberrant D2-receptor responses. These phenomena decline with age, but are stable in littermates. In young GKI, dopamine transients are slower, independent of DAT, increasing dopamine extracellular lifetime. Slowing of dopamine transients is observed with age in littermates, suggesting premature ageing of dopamine synapses in GKI. Thus, GKI mice exhibit early, but declining, synaptic and behavioral phenotypes, making them amenable to investigation of early pathophysiological, and later parkinsonian-like, alterations. This model will prove valuable in efforts to develop neuroprotection for PD.

Article and author information

Author details

  1. Mattia Volta

    Institute for Biomedicine, Bolzano, Italy
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0300-6796
  2. Dayne A Beccano-Kelly

    Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3592-8354
  3. Sarah A Paschall

    Graduate Program in Neuroscience, University of British Columbia, Vancouver, Canada
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1440-4412
  4. Stefano Cataldi

    Graduate Program In Neuroscience, University of British Columbia, Vancouver, Canada
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7708-4124
  5. Sarah E MacIsaac

    Graduate Program in Neuroscience, University of British Columbia, Vancouver, Canada
    Competing interests
    The authors declare that no competing interests exist.
  6. Naila Kuhlmann

    Graduate Program in Neuroscience, University of British Columbia, Vancouver, Canada
    Competing interests
    The authors declare that no competing interests exist.
  7. Chelsie A Kadgien

    Graduate Program in Neuroscience, University of British Columbia, Vancouver, Canada
    Competing interests
    The authors declare that no competing interests exist.
  8. Igor Tatarnikov

    Graduate Program in Neuroscience, University of British Columbia, Vancouver, Canada
    Competing interests
    The authors declare that no competing interests exist.
  9. Jesse Fox

    Graduate Program in Neurosciences, University of British Columbia, Vancouver, Canada
    Competing interests
    The authors declare that no competing interests exist.
  10. Jaskaran Khinda

    Graduate Program in Neurosciences, University of British Columbia, Vancouver, Canada
    Competing interests
    The authors declare that no competing interests exist.
  11. Emma Mitchell

    Graduate Program in Neurosciences, University of British Columbia, Vancouver, Canada
    Competing interests
    The authors declare that no competing interests exist.
  12. Sabrina Bergeron

    Graduate Program in Neurosciences, University of British Columbia, Vancouver, Canada
    Competing interests
    The authors declare that no competing interests exist.
  13. Heather Melrose

    Mayo Clinic, Jacksonville, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Matthew J Farrer

    Department of Medical Genetics, University of British Columbia, Vancouver, Canada
    Competing interests
    The authors declare that no competing interests exist.
  15. Austen J Milnerwood

    Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Canada
    For correspondence
    austen.milnerwood@mcgill.ca
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0056-1778

Funding

Michael J. Fox Foundation for Parkinson's Research

  • Matthew J Farrer
  • Austen J Milnerwood

Parkinson Canada

  • Mattia Volta
  • Stefano Cataldi
  • Chelsie A Kadgien
  • Austen J Milnerwood

Canadian Institutes of Health Research

  • Sarah E MacIsaac
  • Igor Tatarnikov

Canada Excellence Research Chairs, Government of Canada

  • Matthew J Farrer

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Andrew B West, University of Alabama at Birmingham, United States

Ethics

Animal experimentation: Mice were maintained according to Canadian Council on Animal Care regulations and the University of British Columbia Animal Ethics Committee (UBC AAC certification A16-0088 & A15-0105)

Version history

  1. Received: May 9, 2017
  2. Accepted: September 15, 2017
  3. Accepted Manuscript published: September 20, 2017 (version 1)
  4. Version of Record published: October 9, 2017 (version 2)
  5. Version of Record updated: November 2, 2017 (version 3)

Copyright

© 2017, Volta et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,868
    views
  • 552
    downloads
  • 81
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Mattia Volta
  2. Dayne A Beccano-Kelly
  3. Sarah A Paschall
  4. Stefano Cataldi
  5. Sarah E MacIsaac
  6. Naila Kuhlmann
  7. Chelsie A Kadgien
  8. Igor Tatarnikov
  9. Jesse Fox
  10. Jaskaran Khinda
  11. Emma Mitchell
  12. Sabrina Bergeron
  13. Heather Melrose
  14. Matthew J Farrer
  15. Austen J Milnerwood
(2017)
Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in mice
eLife 6:e28377.
https://doi.org/10.7554/eLife.28377

Share this article

https://doi.org/10.7554/eLife.28377

Further reading

    1. Biochemistry and Chemical Biology
    2. Chromosomes and Gene Expression
    Ramona Weber, Chung-Te Chang
    Research Article

    Recent findings indicate that the translation elongation rate influences mRNA stability. One of the factors that has been implicated in this link between mRNA decay and translation speed is the yeast DEAD-box helicase Dhh1p. Here, we demonstrated that the human ortholog of Dhh1p, DDX6, triggers the deadenylation-dependent decay of inefficiently translated mRNAs in human cells. DDX6 interacts with the ribosome through the Phe-Asp-Phe (FDF) motif in its RecA2 domain. Furthermore, RecA2-mediated interactions and ATPase activity are both required for DDX6 to destabilize inefficiently translated mRNAs. Using ribosome profiling and RNA sequencing, we identified two classes of endogenous mRNAs that are regulated in a DDX6-dependent manner. The identified targets are either translationally regulated or regulated at the steady-state-level and either exhibit signatures of poor overall translation or of locally reduced ribosome translocation rates. Transferring the identified sequence stretches into a reporter mRNA caused translation- and DDX6-dependent degradation of the reporter mRNA. In summary, these results identify DDX6 as a crucial regulator of mRNA translation and decay triggered by slow ribosome movement and provide insights into the mechanism by which DDX6 destabilizes inefficiently translated mRNAs.

    1. Chromosomes and Gene Expression
    Marwan Anoud, Emmanuelle Delagoutte ... Jean-Paul Concordet
    Research Article

    Tardigrades are microscopic animals renowned for their ability to withstand extreme conditions, including high doses of ionizing radiation (IR). To better understand their radio-resistance, we first characterized induction and repair of DNA double- and single-strand breaks after exposure to IR in the model species Hypsibius exemplaris. Importantly, we found that the rate of single-strand breaks induced was roughly equivalent to that in human cells, suggesting that DNA repair plays a predominant role in tardigrades’ radio-resistance. To identify novel tardigrade-specific genes involved, we next conducted a comparative transcriptomics analysis across three different species. In all three species, many DNA repair genes were among the most strongly overexpressed genes alongside a novel tardigrade-specific gene, which we named Tardigrade DNA damage Response 1 (TDR1). We found that TDR1 protein interacts with DNA and forms aggregates at high concentration suggesting it may condensate DNA and preserve chromosome organization until DNA repair is accomplished. Remarkably, when expressed in human cells, TDR1 improved resistance to Bleomycin, a radiomimetic drug. Based on these findings, we propose that TDR1 is a novel tardigrade-specific gene conferring resistance to IR. Our study sheds light on mechanisms of DNA repair helping cope with high levels of DNA damage inflicted by IR.